Cite
MLA Citation
Shipra Gandhi et al.. “320 Phase IIa study of alpha-DC1 vaccine against HER2/HER3, chemokine modulation regimen and pembrolizumab in patients with asymptomatic brain metastasis from triple negative or HER2+ breast cancer.” Journal for immunotherapy of cancer, vol. 8, n.d., p. A346. http://access.bl.uk/ark:/81055/vdc_100144730084.0x000006